{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T16:33:19Z","timestamp":1692462799817},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.etap.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T10:05:13Z","timestamp":1298109913000},"page":"436-442","source":"Crossref","is-referenced-by-count":5,"title":["Development of nano alpha-ketoglutarate nebulization formulation and its pharmacokinetic and safety evaluation in healthy human volunteers for cyanide poisoning"],"prefix":"10.1016","volume":"31","author":[{"given":"Shaheen","family":"Sultana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thakuri","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan Jalees","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseem","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2011.02.005_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nano.2008.07.001","article-title":"Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote","volume":"5","author":"Ali","year":"2009","journal-title":"Nanomedicine NBM."},{"key":"10.1016\/j.etap.2011.02.005_bib0010","first-page":"583","article-title":"The influence of exposure route and species on the acute lethal toxicity and tissue concentrations of cyanide","volume":"11","author":"Ballantyne","year":"1983","journal-title":"Dev. Toxicol. Environ. Sci."},{"key":"10.1016\/j.etap.2011.02.005_bib0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/j.1552-4604.1992.tb03849.x","article-title":"The antidotal action of sodium nitrite and sodium thiosulphate against cyanide poisoning","volume":"32","author":"Baskin","year":"1992","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2011.02.005_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0960327107070566","article-title":"Cyanide: critical issues in diagnosis and treatment","volume":"26","author":"Baud","year":"2007","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.etap.2011.02.005_bib0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/occmed\/48.7.427","article-title":"Cyanide poisoning: pathophysiology and treatment recommendations","volume":"4","author":"Beasley","year":"1998","journal-title":"Occup. Med."},{"key":"10.1016\/j.etap.2011.02.005_bib0030","first-page":"24","article-title":"Hydroxocobalamin: New antidote for cyanide poisoning","author":"Beatriz","year":"2007","journal-title":"Pharm. Today"},{"key":"10.1016\/j.etap.2011.02.005_bib0035","first-page":"94","article-title":"Antidotes to cyanide poisoning: present status","volume":"32","author":"Bhattacharya","year":"2000","journal-title":"Ind. J. Pharmacol."},{"key":"10.1016\/j.etap.2011.02.005_bib0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1191\/0960327102ht255oa","article-title":"Promising role of \u03b1-ketoglutarate in protecting the lethal effects of cyanide","volume":"21","author":"Bhattacharya","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.etap.2011.02.005_bib0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/01480540701688865","article-title":"In vitro and in vivo evaluation of various carbonyl compounds against cyanide toxicity with particular reference to alpha-ketoglutaric acid","volume":"31","author":"Bhattacharya","year":"2008","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.etap.2011.02.005_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2008.09.018","article-title":"Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constructive conditions","volume":"71","author":"Bhavna","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.etap.2011.02.005_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/08942680152007909","article-title":"Aerosols and antiinfectious agents","volume":"14","author":"Boissinot","year":"2001","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.etap.2011.02.005_bib0060","series-title":"Acute and Chronic Cyanide Toxicity","first-page":"301","author":"Borowitz","year":"2001"},{"key":"10.1016\/j.etap.2011.02.005_bib0065","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1378\/chest.111.5.1206","article-title":"The choice of jet nebulizer, nebulizing flow and the addition of Ventolin respiratory solution affects tobramycin aerosols used in cystic fibrosis","volume":"111","author":"Coates","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.etap.2011.02.005_bib0070","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/thx.45.10.728","article-title":"Jet and ultrasonic nebulizer output: use of a new method for direct measurement of aerosol output","volume":"45","author":"Dennis","year":"1990","journal-title":"Thorax"},{"key":"10.1016\/j.etap.2011.02.005_bib0075","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1183\/09031936.01.99086801","article-title":"Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis","volume":"18","author":"Dequin","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.etap.2011.02.005_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.mjt.0000174349.89671.8c","article-title":"Hydroxocobalamin as a cyanide antidote","volume":"13","author":"DesLauriers","year":"2006","journal-title":"Am. J. Therap."},{"key":"10.1016\/j.etap.2011.02.005_bib0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/156720109789941623","article-title":"In situ formation of liposome of rifampicin: better availability for better treatment","volume":"6","author":"Gaur","year":"2009","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.etap.2011.02.005_bib0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/10408440802304944","article-title":"Which cyanide antidote","volume":"39","author":"Hall","year":"2009","journal-title":"Rev. Toxicol. Crit."},{"key":"10.1016\/j.etap.2011.02.005_bib0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.TME.0000319922.66978.96","article-title":"Hydroxocobalamin (Cyanokit): a new antidote for cyanide toxicity","volume":"30","author":"Jones","year":"2008","journal-title":"Adv. Emerg. Nurs. J."},{"key":"10.1016\/j.etap.2011.02.005_bib0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.bioeng.10.061807.160544","article-title":"Targeted drug-aerosol delivery in the human respiratory system","volume":"15","author":"Kleinstreuer","year":"2008","journal-title":"Ann. Rev. Biomed. Eng."},{"key":"10.1016\/j.etap.2011.02.005_bib0105","unstructured":"Maduh, E.U., 1989. Mechanism of cyanide neurotoxicity. Ph.D. Thesis submitted to Purdue University, IN, USA, pp. 1\u2013199."},{"key":"10.1016\/j.etap.2011.02.005_bib0110","doi-asserted-by":"crossref","DOI":"10.3109\/15563650.2010.496371","article-title":"Radiolabeling and dose fixation study of oral alpha-ketoglutarate as a cyanide antidote in healthy human volunteers","author":"Mittal","year":"2010","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.etap.2011.02.005_bib0115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/thx.44.9.706","article-title":"Pressurised aerosol deposition in the human lung with and without an open spacer","volume":"44","author":"Newman","year":"1989","journal-title":"Thorax"},{"key":"10.1016\/j.etap.2011.02.005_bib0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-5173(87)90236-5","article-title":"Efficient nebulisation of powdered antibiotics","volume":"36","author":"Newman","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.etap.2011.02.005_bib0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5173(00)00538-X","article-title":"Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products","volume":"208","author":"Newman","year":"2000","journal-title":"J. Pharm. Int."},{"key":"10.1016\/j.etap.2011.02.005_bib0130","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/clinchem\/46.6.848","article-title":"Branched-chain keto-acids and pyruvate in blood: Measurement by HPLC with fluorimetric detection and changes in older subjects","volume":"46","author":"Pailla","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.etap.2011.02.005_bib0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/156720109787048177","article-title":"Development and characterization of mucoadhesive buccal patches of salbutamol sulphate","volume":"6","author":"Patel","year":"2009","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.etap.2011.02.005_bib0140","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.2174\/1381612043383476","article-title":"Radionuclide imaging in drug development","volume":"10","author":"Perkins","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.etap.2011.02.005_bib0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/jam.1997.10.187","article-title":"Tissue attenuation corrections in gamma scintigraphy","volume":"10","author":"Pitcairn","year":"1997","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.etap.2011.02.005_bib0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajem.2008.10.025","article-title":"Clinical and bioavailability studies of sublingually administered atropine sulphate","volume":"28","author":"Rajpal","year":"2010","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.etap.2011.02.005_bib0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.etap.2008.10.007","article-title":"Development of atropine sulphate nasal drops and its pharmacokinetic and safety evaluation in healthy human volunteers","volume":"27","author":"Rajpal","year":"2009","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.etap.2011.02.005_bib0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpharm.2003.09.041","article-title":"Formulation and characterization of spray dried powders containing nanoparticles for aerosol delivery to the lung","volume":"269","author":"Sham","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.etap.2011.02.005_bib0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2125.2002.01632.x","article-title":"Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization","volume":"54","author":"Silkstone","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2011.02.005_bib0170","first-page":"292","article-title":"Tc-99m isoniazid: a specific agent for diagnosis of tuberculosis","volume":"2","author":"Singh","year":"2003","journal-title":"World J. Nucl. Med."},{"key":"10.1016\/j.etap.2011.02.005_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.05.001","article-title":"Effect of sub-acute oral cyanide administration in rats: Protective efficacy of alpha-ketoglutarate and sodium thiosulfate","volume":"156","author":"Tulsawani","year":"2005","journal-title":"Chemico-Biol. Interact."},{"key":"10.1016\/j.etap.2011.02.005_bib0180","first-page":"719","article-title":"Effects of \u03b1-ketoglutarate on some hepatic variables altered by cyanide in vivo and in vitro","volume":"6","author":"Tulsawani","year":"2006","journal-title":"J. Cell Tissue Res."},{"key":"10.1016\/j.etap.2011.02.005_bib0185","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/15563658708992641","article-title":"Therapeutic problems in cyanide poisoning","volume":"25","author":"Van Heijst","year":"1987","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.etap.2011.02.005_bib0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/(SICI)1099-1263(199611)16:6<509::AID-JAT382>3.0.CO;2-V","article-title":"Effectiveness of intramuscularly administered cyanide antidotes on methaemoglobin formation and survival","volume":"16","author":"Vick","year":"1998","journal-title":"J. Appl. Toxicol."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668911000305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668911000305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:42:00Z","timestamp":1592332920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668911000305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1382668911000305"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2011.02.005","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}